Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Accumulated Expenses: 2020-2024

Historic Accumulated Expenses for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $21.1 million.

  • Oncology Institute's Accumulated Expenses rose 4760.95% to $22.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.8 million, marking a year-over-year increase of 4760.95%. This contributed to the annual value of $21.1 million for FY2024, which is 5070.73% up from last year.
  • Per Oncology Institute's latest filing, its Accumulated Expenses stood at $21.1 million for FY2024, which was up 5070.73% from $14.0 million recorded in FY2023.
  • In the past 5 years, Oncology Institute's Accumulated Expenses ranged from a high of $21.1 million in FY2024 and a low of $9.5 million during FY2020
  • Moreover, its 5-year median value for Accumulated Expenses was $14.0 million (2023), whereas its average is $14.6 million.
  • As far as peak fluctuations go, Oncology Institute's Accumulated Expenses tumbled by 410.41% in 2023, and later surged by 5070.73% in 2024.
  • Annual analysis of 5 years shows Oncology Institute's Accumulated Expenses stood at $9.5 million in 2020, then surged by 47.31% to $13.9 million in 2021, then increased by 4.82% to $14.6 million in 2022, then decreased by 4.1% to $14.0 million in 2023, then surged by 50.71% to $21.1 million in 2024.
  • Its last three reported values are $21.1 million in FY2024, $14.0 million for FY2023, and $14.6 million during FY2022.